Bayer’s Eylea AMD Drug Hits Cost Evaluation Hurdle

06.01.2014 - Bayer HealthCare has hit a stumbling block in the sales campaign for its new drug Eylea (aflibercept), or VEGF Trap-Eye, recommended for treatment of age-related wet macula...